Q9Y279 (VSIG4_HUMAN) Homo sapiens (Human)
V-set and immunoglobulin domain-containing protein 4 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
7 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Nanobody targeting human Vsig4 in Spacegroup P212121 |
Heteromer | |||||
Assess | ||||||
CRIg bound to C3c |
Heteromer P01024; | 1×NAG; 1×CA; | ||||
Assess | ||||||
CRIg bound to C3b |
Heteromer P01024; | 1×NAG; 1×CA; 1×NAG; | ||||
Assess | ||||||
Nanobody targeting human Vsig4 in Spacegroup C2 |
Heteromer | |||||
Assess | ||||||
Extracellular Domain of CRIg | monomer | |||||
Assess | ||||||
Crystal structure of a multiple lysine-to-arginine substitution mutant of the human CRIg C3b-bindin… | monomer | |||||
Assess | ||||||
Crystal structure of a multiple lysine-to-arginine substitution mutant of the human CRIg C3b-bindin… | monomer | |||||
Assess |
3 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 7pkl.1.B | monomer | 0.51 | 16.33 | ||
Assess | ||||||
Isoform 2 | 4myw.1.B | monomer | 0.51 | 20.83 | ||
Assess | ||||||
Isoform 3 | 5imm.1.B | monomer | 0.76 | 78.51 | ||
Assess |